Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 53, Issue 43, Pages 11583-11586Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201405990
Keywords
antifungal agents; genomics; natural products; NMR spectroscopy; structure elucidation
Categories
Funding
- University of Wisconsin-Madison School of Pharmacy
- NIH, NIGMS [R01 GM092009]
- DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]
- National Institutes of Health [1R01HG005084-01A1, 1R01M104975-01, R01HG005853]
- National Science Foundation [DBI 0953881]
- CIFAR Genetic Networks Program
- NIH [P41RR02301, P41M66326, RR02781, RR08438]
- University of Wisconsin [BIR-9512577, S10RR13790]
- NSF [DMB-8415048, OIA-9977486, BIR-9214394]
- USDA
- [R01 GM104192]
Ask authors/readers for more resources
ForazolineA, a novel antifungal polyketide with invivo efficacy against Candida albicans, was discovered using LCMS-based metabolomics to investigate marine-invertebrate-associated bacteria. ForazolineA had a highly unusual and unprecedented skeleton. Acquisition of C-13-C-13 gCOSY and C-13-N-15 HMQCNMR data provided the direct carbon-carbon and carbon-nitrogen connectivity, respectively. This approach represents the first example of determining direct C-13-N-15 connectivity for a natural product. Using yeast chemical genomics, we propose that forazolineA operated through a new mechanism of action with a phenotypic outcome of disrupting membrane integrity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available